Tirzepatide (MJ)

Tirzepatide is a synthetic peptide designed to activate both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-receptor activity makes tirzepatide an important research compound for investigating interconnected metabolic and endocrine signaling pathways. The 10 mg presentation is intended for qualified research environments requiring a defined quantity of tirzepatide for controlled laboratory investigations. It may be used as a research material in studies examining receptor pharmacology, peptide activity, metabolic signaling, and related preclinical models.

Key Features

10 mg research-grade peptide Tirzepatide / MJ Dual GIP and GLP-1 receptor agonist Suitable for controlled laboratory research Relevant to metabolic and endocrine signaling studies Intended for in-vitro and preclinical research workflows Suitable for research programs requiring analytical and batch-level documentation Research Focus Tirzepatide’s dual activity at GIP and GLP-1 receptors provides researchers with a useful model for investigating receptor-mediated signaling and metabolic pathways. Research applications may include studies of peptide pharmacology, receptor interactions, metabolic signaling, and related biological mechanisms.

Important Notice

This product is supplied strictly for research and laboratory use. It is not intended for human or veterinary use, consumption, self-administration, diagnosis, treatment, or prevention of disease. This research material should be handled only by appropriately qualified personnel in accordance with applicable laboratory protocols and regulations